CIBC World Market
TEVA icon

CIBC World Market’s Teva Pharmaceuticals TEVA Stock Holding History

CIBC World Market’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14M Buy
92,543
+29,505
+47% +$983K 0.01% 735
2026
Q1 		$1.9M Sell
63,038
-6,325
-9% -$203K ﹤0.01% 770
2025
Q4 		$2.16M Sell
69,363
-3,300
-5% -$81.3K ﹤0.01% 763
2025
Q3 		$1.47M Buy
72,663
+3,663
+5% +$64.3K ﹤0.01% 853
2025
Q2 		$1.16M Buy
69,000
+1,382
+2% +$22.3K ﹤0.01% 859
2025
Q1 		$1.04M Sell
67,618
-39,649
-37% -$708K ﹤0.01% 867
2024
Q4 		$2.36M Sell
107,267
-22,529
-17% -$410K 0.01% 685
2024
Q3 		$2.34M Sell
129,796
-2,192
-2% -$38.4K ﹤0.01% 640
2024
Q2 		$2.15M Sell
131,988
-6,410
-5% -$98.7K ﹤0.01% 637
2024
Q1 		$1.95M Buy
138,398
+72,076
+109% +$909K ﹤0.01% 654
2023
Q4 		$692K Sell
66,322
-24,755
-27% -$231K ﹤0.01% 863
2023
Q3 		$929K Buy
91,077
+2,900
+3% +$27K ﹤0.01% 751
2023
Q2 		$664K Buy
88,177
+800
+0.9% +$6.49K ﹤0.01% 863
2023
Q1 		$773K Sell
87,377
-2,900
-3% -$28.7K ﹤0.01% 813
2022
Q4 		$823K Sell
90,277
-4,086
-4% -$35.7K ﹤0.01% 810
2022
Q3 		$762K Buy
94,363
+15,075
+19% +$133K ﹤0.01% 784
2022
Q2 		$596K Sell
79,288
-895
-1% -$7.8K ﹤0.01% 839
2022
Q1 		$753K Sell
80,183
-244
-0.3% -$2.04K ﹤0.01% 807
2021
Q4 		$644K Sell
80,427
-690
-0.9% -$6.23K ﹤0.01% 912
2021
Q3 		$790K Buy
81,117
+3,420
+4% +$32K ﹤0.01% 844
2021
Q2 		$769K Buy
77,697
+800
+1% +$8.47K ﹤0.01% 858
2021
Q1 		$887K Sell
76,897
-7,600
-9% -$87.1K ﹤0.01% 804
2020
Q4 		$815K Sell
84,497
-18,600
-18% -$178K ﹤0.01% 801
2020
Q3 		$929K Sell
103,097
-56,906
-36% -$602K ﹤0.01% 665
2020
Q2 		$1.97M Buy
160,003
+6,644
+4% +$75.1K 0.01% 483
2020
Q1 		$1.38M Sell
153,359
-11,685
-7% -$120K 0.01% 483
2019
Q4 		$1.62M Sell
165,044
-77,802
-32% -$695K 0.01% 550
2019
Q3 		$1.67M Sell
242,846
-5,039
-2% -$38.6K 0.01% 506
2019
Q2 		$2.29M Sell
247,885
-136,044
-35% -$1.64M 0.01% 448
2019
Q1 		$6.02M Sell
383,929
-41,855
-10% -$738K 0.03% 265
2018
Q4 		$6.57M Sell
425,784
-110,359
-21% -$2.26M 0.03% 226
2018
Q3 		$11.5M Buy
536,143
+46,887
+10% +$1.09M 0.05% 173
2018
Q2 		$11.9M Buy
489,256
+93,126
+24% +$1.9M 0.05% 175
2018
Q1 		$6.77M Buy
396,130
+256,698
+184% +$5.01M 0.03% 236
2017
Q4 		$2.64M Sell
139,432
-32,611
-19% -$491K 0.01% 270
2017
Q3 		$3.03M Sell
172,043
-74,898
-30% -$1.69M 0.01% 234
2017
Q2 		$8.2M Buy
246,941
+28,423
+13% +$880K 0.03% 227
2017
Q1 		$7.01M Buy
218,518
+126,456
+137% +$4.32M 0.02% 229
2016
Q4 		$3.34M Buy
92,062
+38,715
+73% +$1.55M 0.01% 303
2016
Q3 		$2.45M Sell
53,347
-42,593
-44% -$2.22M 0.01% 321
2016
Q2 		$4.82M Sell
95,940
-23,463
-20% -$1.25M 0.02% 194
2016
Q1 		$6.39M Sell
119,403
-7,148
-6% -$419K 0.03% 143
2015
Q4 		$8.31M Buy
126,551
+19,169
+18% +$1.18M 0.04% 112
2015
Q3 		$6.06M Buy
107,382
+22,220
+26% +$1.44M 0.03% 131
2015
Q2 		$5.03M Buy
85,162
+1,854
+2% +$114K 0.02% 170
2015
Q1 		$5.19M Buy
83,308
+3,879
+5% +$226K 0.02% 166
2014
Q4 		$4.57M Buy
79,429
+53,667
+208% +$2.99M 0.02% 167
2014
Q3 		$1.39M Sell
25,762
-20,328
-44% -$1.08M 0.01% 351
2014
Q2 		$2.42M Buy
46,090
+2,694
+6% +$138K 0.01% 263
2014
Q1 		$2.29M Sell
43,396
-33,928
-44% -$1.57M 0.01% 260
2013
Q4 		$3.1M Sell
77,324
-30,235
-28% -$1.19M 0.01% 199
2013
Q3 		$4.06M Sell
107,559
-13,420
-11% -$523K 0.02% 134
2013
Q2 		$4.74M Buy
+120,979
New +$4.71M 0.02% 103

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

CIBC World Market's TEVA Position: Q2 2026 in Review

CIBC World Market increased its Teva Pharmaceuticals (TEVA) stake by 47% in Q2 2026, buying an estimated $983K and bringing the position to 92,543 shares worth $3.14M. The position accounts for 0.01% of the portfolio, ranked #735.

CIBC World Market first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.9M in Q2 2018. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • CIBC World Market held 92,543 shares of Teva Pharmaceuticals worth $3.14M as of Q2 2026.
  • CIBC World Market bought 29,505 Teva Pharmaceuticals shares in Q2 2026, an estimated $983K.
  • Teva Pharmaceuticals made up 0.01% of CIBC World Market's portfolio in Q2 2026, its #735 holding.
  • CIBC World Market first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • CIBC World Market's Teva Pharmaceuticals position peaked at $11.9M in Q2 2018.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.